Mmu_circ_0005373 and hsa_circ_0136255 participate in the pulmonary fibrosis of systemic sclerosis
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.112690 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Xiaolin Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The Third People's Hospital of Longgang District, Shenzhen 518115, China; Guangdong Key Laboratory for Biomedical Measureme…. Hauptthemen laut MEDLINE: Scleroderma, Systemic, RNA, Circular, Pulmonary Fibrosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
The pathogenesis of SSc pulmonary fibrosis is complex and prognosis is poor. In order to find biomarkers to provide assistance in the diagnosis and treatment of systemic sclerosis (SSc), this study explored the role of SSc-related differentially expressed circRNAs in the fibrosis process. This study explored whether circular RNA (circRNA) mediated the mTOR signaling pathway by interacting with the eukaryotic translation initiation factor eIF4E-binding protein 1 (4E-BP1), participated in a competing endogenous RNA (ceRNA) network, and regulated the mechanism of pulmonary fibrosis in systemic sclerosis (SSc). The results showed that the expression of mmu_circ_0005373 was reduced, and mmu_circ_0005373 may regulate the mTOR signaling pathway by inhibiting the interacting with 4E-BP1 protein in the lung of SSc mice, and promote fibrosis in SSc. Hsa_circ_0136255, which is homologous to mmu_circ_0005373, is also reduced in SSc peripheral blood mononuclear cells, and predicted to interact with 4E-BP1 protein. Hsa_circ_0136255/hsa-miR-330-3p/TNFAIP3 ceRNA network had biological significance in SSc, and correlated with clinical data, including high-resolution CT, average expiratory flow at 25% vital capacity, neutrophil count, lymphocyte percentage, standard deviation of red blood cell distribution width, coefficient of variation of red blood cell distribution width, platelet distribution width, glutamic transaminase, γ-glutamyl transpeptidase, lymphocyte percentage, basophils percentage, red blood cell, plateletcrit, cholinesterase, and mean corpuscular hemoglobin concentration. Hsa_circ_0136255, hsa-miR-330-3p, and TNFAIP3 may be used as biomarkers for clinical diagnosis and treatment of SSc.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, The Third People's Hospital of Longgang District, Shenzhen 518115, China; Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, National-Regional Key Technology Engineeri…
- Key Autoimmunity Laboratory of Inner Mongolia, Department of Rheumatology, the First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou 014010, China.
- Key Autoimmunity Laboratory of Inner Mongolia, Department of Rheumatology, the First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou 014010, China. Electronic a…
Zitieren
APA
Sun, X., Wang, B., Ding, L., Ding, T., Wang, Y., & Xu, M. (2024). Mmu_circ_0005373 and hsa_circ_0136255 participate in the pulmonary fibrosis of systemic sclerosis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112690
Vancouver
Sun X, Wang B, Ding L, Ding T, Wang Y, Xu M. Mmu_circ_0005373 and hsa_circ_0136255 participate in the pulmonary fibrosis of systemic sclerosis. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112690
BibTeX
@article{Sun2024,
author = {Sun, Xiaolin and Wang, Baoyue and Ding, Lili and Ding, Tiantian and Wang, Yongfu and Xu, Mingguo},
title = {Mmu_circ_0005373 and hsa_circ_0136255 participate in the pulmonary fibrosis of systemic sclerosis},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.112690}
}
EUVIMED